10:33 AM EST - Aptose Biosciences Inc. : Has secured a short-term cash advance from Dr. William G. Rice, the Company’s Chairman of the Board, President and Chief Executive Officer, to support near-term obligations, including payroll, and to enable continued advancement of its clinical-stage oral kinase inhibitor, tuspetinib, while it engages in ongoing negotiations with prospective funding partners. Aptose Biosciences Inc.
shares T.APS are trading down $0.28 at $2.10.
